Scholars Central

Conference abstractPublished 24 May 2021

Treatment resistant depression

Authors: Jillian Bonzani

Journal of Psychiatry

Volume 24 · Issue 5 · Pages 1

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Major Depressive Disorder is a mental health disorder that affects nearly 16.1 million adults each year (NIMH, 2018). The disorder is characterized of more than a 2-week period containing more than five of the following symptoms: low mood, anergia, fatigue, weight loss or gain, suicidal ideation, worthlessness, guilt, psychomotor retardation, hypersomnia or insomnia, and impaired concentration (Diagnostic and Statistical Manual of Mental Disorders, 5th Edition, 2014). Treatment-resistant depression (TRD) is defined as depression that has failed to respond to two adequate pharmacological interventions. TRD can last months to years with no relief. Those with TRD expierience decrease in quality of life, impaired cognitive function, increase in inpatient hospitalizations, increased risk for suicide (Mathew et al., 2019). Alternative treatments are such as electroconvulsive therapy (ECT), and ketamine infusions are not used until a person has had at least two failed trials of antidepressants. The cost of the treatments can be high, not covered by insurance, and can cause more serious side effects than most pharmacological treatments. The purpose of this study is to examine evidence based, peer reviewed studies that can determine the best alternative treatment for depression. The rationale for doing this study is to create a better quality of life, improvement and remission of depressive symptoms, and better health outcomes. The value of this study is to apply in clinical practice the most effective treatment for TRD, educating patients with TRD of their alternative options. The research question for the literature review is “In people with Major Depressive Disorder, what is the effect of ECT, in comparison to ketamine, on improvement in their depressive symptoms over one year?” This study will examine the efficacy, side effects, and remission of the treatments. Thirteen primary resources were critiqued and analyzed for this scholarly research project. All studies that were analyzed were quantitative (Basso et al., 2019; Fava et al., 2018; Ghasemi et al., 2015; Kellner et al., 2016; Kellner et al., 2016; Kheirabadi et al., 2019; Lee et al., 2015; Mathew et al., 2019; Phillips et al., 2020; Sakurai et al., 2015; Semovska et al., 2016; Sharma et al., 2020; Singh et al., 2016). The critique of the articles included research of the designs, methods and instruments used in these twelve studies which were all reviewed for validity and reliability of measurement tools in order to determine the integrity and credibility of the studies (Coughlan et al., 2007).

Keywords

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Psychiatry.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Psychiatry
  • SubjectMental Health and Psychology
  • BylineArticles whose byline prints “Jillian Bonzani”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels